Evidence map›Paper›PMID 42485583›Full record

ArticleACS nano2026

Hybrid Nonviral Nanocarriers Enable Functional Neural Modulation.

Eunji Hong, Xinxin Xu, Sizhe Huang, Geunho Jang, Zuer Wu, Qianbin Wang, Siyuan Rao

Abstract read
In one paragraph

Article in ACS nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eunji HongDepartment of Biomedical Engineering, Binghamton University, State University of New York, Binghamton, New York13902, United States.ORCID 0000-0003-3294-1780
Xinxin XuDepartment of Biomedical Engineering, Binghamton University, State University of New York, Binghamton, New York13902, United States.
Sizhe HuangDepartment of Biomedical Engineering, Binghamton University, State University of New York, Binghamton, New York13902, United States.
Geunho JangDepartment of Biomedical Engineering, Binghamton University, State University of New York, Binghamton, New York13902, United States.
Zuer WuDepartment of Biomedical Engineering, Binghamton University, State University of New York, Binghamton, New York13902, United States.
Qianbin WangDepartment of Biomedical Engineering, Binghamton University, State University of New York, Binghamton, New York13902, United States.ORCID 0000-0002-9840-6732
Siyuan RaoDepartment of Biomedical Engineering, Binghamton University, State University of New York, Binghamton, New York13902, United States.ORCID 0000-0002-1555-487X

Funding

Magnetic Modulation on Targeted Neural Circuits in AutismR00MH120279 · NIMH · UNIVERSITY OF MASSACHUSETTS AMHERST · PI RAO, SIYUAN · 2021 to 2023
$747k
Identifying Cellular Intraspinal Electrophysiological Features of "Spinal Shock"R21NS144777 · NINDS · STATE UNIVERSITY OF NY,BINGHAMTON · PI HE, ZHIGANG, RAO, SIYUAN · 2025 to 2025
$470k
Air Force Office of Scientific Research Young Investigator Program, FA9550-23-1-0339Binghamton University Faculty Startup FundsBinghamton University S3IP Small Grant Awards, ADLG 267Binghamton University S3IP Small Grant Awards, ADLG 274Binghamton University S3IP Small Grant Awards, ADLG 324Binghamton University Transdisciplinary Areas of Excellence (TAE) prograBinghamton University Watson College of Engineering and Applied ScienceBrain and Behavior Research Foundation Young Investigator Grant, 29878Craig H. Neilsen Foundation SCIRTS Pilot Research Grant, 1348565National Institutes of Health (NIH) R00MH120279National Institutes of Health (NIH) R21NS144777National Science Foundation (NSF) Faculty Early Career Development Program, 2414753National Science Foundation (NSF) Faculty Early Career Development Program, 2442112NIMH NIH HHS R00 MH120279NINDS NIH HHS R21 NS144777S.H. Ho Foundation Research Grants Health Sciences and Technology
6 · The paper itself

Abstract

Extracellular vesicles released from the neuronal cells mediate the transfer of proteins, nucleic acids, and neurotransmitter-related cargoes, shaping gene expression and intercellular communication across neural circuits. Leveraging this endogenous pathway, we fused astrocyte-derived exosomes with RNA-loaded synthetic liposomes to create sub-100 nm hybrid nanoparticles for central nervous system delivery. This design addresses key limitations of existing systems: conventional liposomes lack cell-type specificity and can be toxic, whereas native vesicles are difficult to load efficiently. By tuning a mildly cationic surface, the hybrids support efficient gene transfer to neurons without disrupting membrane integrity or inducing measurable cytotoxicity. We validated this platform in vivo by delivering Cre recombinase mRNA in transgenic mice and inducing channel rhodopsin-2 expression in the motor cortex and ventral tegmental area, yielding behavioral changes during optogenetic stimulation.

Indexed as

Gene Transfer TechniquesNanoparticlesNeuronsAnimalsAstrocytesExosomesIntegrasesLiposomesMiceMice, TransgenicOptogeneticsRNA, MessengerCre recombinaseIntegrasesLiposomesRNA, Messengerexosomesgene deliveryliposomesneural modulationnonviral nanocarriersoptogenetics

Identifiers

PMID42485583
PMCPMC13450448

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.